ZA200104301B - The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases relaed to a particular age and for prolonging life. - Google Patents

The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases relaed to a particular age and for prolonging life.

Info

Publication number
ZA200104301B
ZA200104301B ZA200104301A ZA200104301A ZA200104301B ZA 200104301 B ZA200104301 B ZA 200104301B ZA 200104301 A ZA200104301 A ZA 200104301A ZA 200104301 A ZA200104301 A ZA 200104301A ZA 200104301 B ZA200104301 B ZA 200104301B
Authority
ZA
South Africa
Prior art keywords
relaed
utilisation
medicament
inhibitors
diseases
Prior art date
Application number
ZA200104301A
Other languages
English (en)
Inventor
Wolfgang Linz
Hans-Jochen Lang
Bela Kelety
Peter Schmid
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of ZA200104301B publication Critical patent/ZA200104301B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
ZA200104301A 1998-12-23 2001-05-25 The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases relaed to a particular age and for prolonging life. ZA200104301B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19859727A DE19859727A1 (de) 1998-12-23 1998-12-23 Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung

Publications (1)

Publication Number Publication Date
ZA200104301B true ZA200104301B (en) 2003-02-20

Family

ID=7892436

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200104301A ZA200104301B (en) 1998-12-23 2001-05-25 The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases relaed to a particular age and for prolonging life.

Country Status (20)

Country Link
US (1) US6420430B1 (ko)
EP (1) EP1140056A2 (ko)
JP (1) JP2002533386A (ko)
KR (1) KR20010086152A (ko)
CN (1) CN1367689A (ko)
AR (1) AR021965A1 (ko)
AU (1) AU776761B2 (ko)
BR (1) BR9916505A (ko)
CA (1) CA2357837A1 (ko)
CZ (1) CZ20012309A3 (ko)
DE (1) DE19859727A1 (ko)
HR (1) HRPK20010470B1 (ko)
HU (1) HUP0104652A3 (ko)
IL (1) IL143372A0 (ko)
NO (1) NO20013145L (ko)
RU (1) RU2238721C2 (ko)
SK (1) SK9042001A3 (ko)
TR (1) TR200101803T2 (ko)
WO (1) WO2000038661A2 (ko)
ZA (1) ZA200104301B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844361B2 (en) * 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
RU2004126702A (ru) * 2002-02-04 2005-04-20 АВЕНТИС ФАРМА ДОЙЧЛАНД ГмбХ (DE) Комбинированный препарат на основе ингибитора натрий-водородного обмена карипорида с ингибиторами ангиотензинконвертирующего фермента для предотвращения сердечной недостаточности и других, обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
BRPI0411900B8 (pt) * 2003-06-26 2021-05-25 Biotron Ltd compostos e composições farmacêuticas compreendendo os mesmos
US8017863B2 (en) * 2005-11-02 2011-09-13 The Regents Of The University Of Michigan Polymer wrapped carbon nanotube near-infrared photoactive devices
US7947897B2 (en) * 2005-11-02 2011-05-24 The Trustees Of Princeton University Organic photovoltaic cells utilizing ultrathin sensitizing layer
US8013240B2 (en) * 2005-11-02 2011-09-06 The Trustees Of Princeton University Organic photovoltaic cells utilizing ultrathin sensitizing layer
KR101042078B1 (ko) * 2009-01-13 2011-06-16 한국항공우주산업 주식회사 치공구 제작용 수평 측면 가공 치구
CN104103253B (zh) 2014-07-04 2016-08-17 京东方科技集团股份有限公司 发射电极扫描电路、阵列基板和显示装置

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0589336T3 (da) * 1992-09-22 1997-06-16 Hoechst Ag Benzylguanidiner, fremgangsmåde til deres fremstilling samt deres anvendelse som antiarytmetika
EP0590455B1 (en) * 1992-09-28 2000-12-27 Hoechst Aktiengesellschaft Antiarrhythmic and cardioprotective substituted 1(2H)-isoquinolines, process for their production, medicament containing them and their use for the production of a medicament for combating heart failures
SE508028C2 (sv) * 1993-05-12 1998-08-10 Moelnlycke Ab Midjebälte för absorberande plagg
DE4328352A1 (de) 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0669666B1 (en) 1994-02-25 1997-12-17 WHITEHEAD ALENIA SISTEMI SUBACQUEI S.p.A. Electrolyte-activated battery
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19502644A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
DE19502895A1 (de) 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DK0738712T3 (da) * 1995-04-18 2000-03-06 Hoechst Ag Substituerede indenoylguanidiner med antiarytmetisk kardioprotektiv virkning
EP0765867A1 (de) 1995-09-27 1997-04-02 Hoechst Aktiengesellschaft Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621319A1 (de) * 1996-05-28 1997-12-04 Hoechst Ag Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19622222A1 (de) * 1996-06-03 1997-12-04 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
WO1998055475A1 (en) * 1997-06-02 1998-12-10 Fujisawa Pharmaceutical Co., Ltd. Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
DE19734693A1 (de) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
CA2260499A1 (en) * 1998-01-29 1999-07-29 Sumitomo Pharmaceuticals Company Limited Pharmaceutical compositions for the treatment of ischemic brain damage

Also Published As

Publication number Publication date
NO20013145D0 (no) 2001-06-22
SK9042001A3 (en) 2001-12-03
JP2002533386A (ja) 2002-10-08
HUP0104652A3 (en) 2002-09-30
TR200101803T2 (tr) 2001-10-22
AU776761B2 (en) 2004-09-23
RU2001120358A (ru) 2005-12-10
WO2000038661A2 (de) 2000-07-06
AU1657600A (en) 2000-07-31
AR021965A1 (es) 2002-09-04
IL143372A0 (en) 2002-04-21
BR9916505A (pt) 2001-11-20
CZ20012309A3 (cs) 2001-09-12
HRP20010470A2 (en) 2002-06-30
KR20010086152A (ko) 2001-09-08
EP1140056A2 (de) 2001-10-10
HRPK20010470B1 (en) 2003-10-31
RU2238721C2 (ru) 2004-10-27
DE19859727A1 (de) 2000-06-29
WO2000038661A3 (de) 2000-11-09
US6420430B1 (en) 2002-07-16
HUP0104652A2 (hu) 2002-03-28
NO20013145L (no) 2001-08-22
CN1367689A (zh) 2002-09-04
CA2357837A1 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
GB9913756D0 (en) New O-acyloxime photoinitiators
ZA974828B (en) Use of inhibitors of the cellular Na<+>/H<+> exchanger (NHE) for the production of a medicament for the normalization of serum lipids.
HUP0101613A3 (en) Metalloprotease inhibitor (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides and medicaments containing the same
ZA200104301B (en) The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases relaed to a particular age and for prolonging life.
AU138275S (en) Menstrual pad having thermal cells
BG105527A (en) Nonsteroid antiinflammatories
GB9717718D0 (en) Memory management with compaction of data blocks
ZA200108413B (en) Use of glycosyceramide synthesis inhibitors in therapy.
HUP0200222A2 (en) Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds and pharmaceutical compositions containing them
HUP0200386A3 (en) Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity and pharmaceutical compositions containing them and their use
HUP9801924A3 (en) Combination containing sodium/hydrogen exchange inhibitors
IL125114A0 (en) Use of inhibitor of the cellular na+/h+ exchanger (nhe) for the production of a medicament for respiratory stimulation
AU751977C (en) Sodium/proton antiporter gene
GB9900398D0 (en) Arrangements of electrochemical cells
ZA989536B (en) Medical face mask.
EP1009047A4 (en) BATTERY PLATE AND BATTERY
AU1784900A (en) Compositions in anhydrous medium comprising active principles releasing a gas incontact with water, and uses thereof
AU1959200A (en) New utilization of alpha-hidroxy-propionic acid in medicine
MA26840A1 (fr) Cristaux d'inhibiteur d'echangeur sodium-hydrogene de type 1
GB2329496B (en) Tidal calculator
SG105471A1 (en) Improvements relating to the storage, exchange and manipulation of electronic information
GB9801544D0 (en) Full face helmet modifications
TW398199U (en) Improved structure for assembling and forming shoes shell
PL108071U1 (en) Dental matrix tape
PL108070U1 (en) Dental matrix tape